Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 14
2017 15
2018 32
2019 14
2020 21
2021 12
2022 12
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Microvascular Complications of Type 2 Diabetes Mellitus.
Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Faselis C, et al. Among authors: imprialos k. Curr Vasc Pharmacol. 2020;18(2):117-124. doi: 10.2174/1570161117666190502103733. Curr Vasc Pharmacol. 2020. PMID: 31057114 Review.
Diabetes and lipid metabolism.
Athyros VG, Doumas M, Imprialos KP, Stavropoulos K, Georgianou E, Katsimardou A, Karagiannis A. Athyros VG, et al. Among authors: imprialos kp. Hormones (Athens). 2018 Mar;17(1):61-67. doi: 10.1007/s42000-018-0014-8. Epub 2018 Apr 16. Hormones (Athens). 2018. PMID: 29858856 Review.
Hypertension in Metabolic Syndrome: Novel Insights.
Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros V. Katsimardou A, et al. Among authors: imprialos k. Curr Hypertens Rev. 2020;16(1):12-18. doi: 10.2174/1573402115666190415161813. Curr Hypertens Rev. 2020. PMID: 30987573 Review.
Pharmacological Management of Type 2 Diabetes Complications.
Doumas M, Imprialos K, Stavropoulos K, Athyros VG. Doumas M, et al. Among authors: imprialos k. Curr Vasc Pharmacol. 2020;18(2):101-103. doi: 10.2174/157016111802200101155519. Curr Vasc Pharmacol. 2020. PMID: 32013814 No abstract available.
Primary Aldosteronism: Novel Insights.
Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, Doumas M. Stavropoulos K, et al. Among authors: imprialos k. Curr Hypertens Rev. 2020;16(1):19-23. doi: 10.2174/1573402115666190415155512. Curr Hypertens Rev. 2020. PMID: 30987572 Review.
Dysmetabolic Iron Overload in Metabolic Syndrome.
Sachinidis A, Doumas M, Imprialos K, Stavropoulos K, Katsimardou A, Athyros VG. Sachinidis A, et al. Among authors: imprialos k. Curr Pharm Des. 2020;26(10):1019-1024. doi: 10.2174/1381612826666200130090703. Curr Pharm Des. 2020. PMID: 32000639 Review.
Is very low LDL-C harmful?
Faselis C, Imprialos K, Grassos H, Pittaras A, Kallistratos M, Manolis A. Faselis C, et al. Among authors: imprialos k. Curr Pharm Des. 2018;24(31):3658-3664. doi: 10.2174/1381612824666181008110643. Curr Pharm Des. 2018. PMID: 30295187 Review.
Impact of Primary Aldosteronism in Resistant Hypertension.
Stavropoulos K, Imprialos KP, Patoulias D, Katsimardou A, Doumas M. Stavropoulos K, et al. Among authors: imprialos kp. Curr Hypertens Rep. 2022 Aug;24(8):285-294. doi: 10.1007/s11906-022-01190-9. Epub 2022 Apr 21. Curr Hypertens Rep. 2022. PMID: 35445928 Review.
113 results